Pain and Comfort in Diabetic Foot Ulcer Care
Launched by MARDIN ARTUKLU UNIVERSITY · Oct 14, 2024
Trial Information
Current as of June 17, 2025
Completed
Keywords
ClinConnect Summary
Diabetic foot ulcer (DFU) prevalence is increasing in parallel with the increasing number of patients with diabetes mellitus (DM). Patients experience pain due to debridement, which is frequently used in DFU care. Therefore, it is seen that nonpharmacological strategies are needed in pain management, unlike pharmacological methods. For this purpose, this single-blind randomized controlled study attempted to provide more information to the literature for supportive care in DFU care. 68 DFU patients were included in the study. After being randomly assigned to the groups, the care solution was...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients over the age of 18 with a diabetic foot wound diagnosed with diabetes mellitus,
- • No cognitive impairment,
- • No hearing, understanding or speaking problems,
- • VAS\>3 points,
- • Patients who consent to participate in the study
- Exclusion Criteria:
- • Patients who have been decided to have an intervention to reduce pain before the procedure (such as local anesthesia, nerve blockade, opioid analgesics, etc.) -Patients with VAS \<3 points,
- • Patients with arterial or venous ulcers other than DFU
About Mardin Artuklu University
Mardin Artuklu University is a distinguished academic institution committed to advancing research and education in various fields, including health sciences. As a clinical trial sponsor, the university leverages its expertise and resources to facilitate innovative research initiatives aimed at improving patient outcomes and enhancing medical knowledge. With a focus on ethical standards and scientific rigor, Mardin Artuklu University fosters collaboration among researchers, healthcare professionals, and industry partners to drive impactful clinical studies that address pressing health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Diyarbakır, , Turkey
Patients applied
Trial Officials
Mensure Turan, PhD
Principal Investigator
Şırnak Üniversitesi
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported